SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹87 Cr | ₹80 Cr | ₹96 Cr | ₹100 Cr | ₹146 Cr |
What is the latest Total Current Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹96 Cr |
| Mar2022 | ₹100 Cr |
| Mar2021 | ₹146 Cr |
How is Total Current Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 9.58 | |
| Mar2024 | ₹80 Cr | -16.92 | |
| Mar2023 | ₹96 Cr | -3.93 | |
| Mar2022 | ₹100 Cr | -31.72 | |
| Mar2021 | ₹146 Cr | - | |
Compare Total Current Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,712.7 Cr | 6.1% | -4.5% | -10.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 6.1% |
-4.5% |
-10.5% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses